AMINA Becomes First Regulated Bank on 21X, Europe’s First Fully Regulated DLT Trading and Settlement Venue
Along with Tokeny, the combined tokenisation suite creates a complete tokenisation infrastructure, from regulated custody to onchain trading and settlement ZUG,... Read more.
MIPS and Green Hills Software Accelerate Safety Certified Product Development for MIPS RISC-V Microcontrollers
Collaboration accelerates time-to-market for mission-critical applications in automotive and industrial markets Designed for real-time, event-driven Physical AI... Read more.
Agilent to Acquire Biocare Medical, a Global Leader in Clinical and Research Pathology Solutions
Expands Agilent’s pathology portfolio through addition of highly complementary antibody, reagent and instrument business with annual double-digit revenue and profit... Read more.
Guangdong Signals Push Into Advanced Technologies as China Prepares Next Five-year Plan
GUANGZHOU, China–(BUSINESS WIRE)–Guangdong, China’s largest provincial economy and a key hub of global manufacturing, plans to deepen its focus on... Read more.
GigaDevice Strengthens Global Presence at Embedded World 2026, Showcasing System-Level Innovations for Humanoid Robotics, Industry, and Edge AI
Wide range of demonstrations on display at Hall 5, 5-129 throughout the March 10-12 show NUREMBERG, Germany–(BUSINESS WIRE)–#analog—GigaDevice,... Read more.
GenSight Biologics Provides Updates about GS010/LUMEVOQ® Early Access Programs and the Ongoing REVISE Study
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing... Read more.
ENHERTU® Granted Priority Review in the U.S. as Post-Neoadjuvant Treatment for Patients with HER2 Positive Early Breast Cancer
Based on DESTINY-Breast05 phase 3 trial results, which showed ENHERTU reduced the risk of invasive disease recurrence or death by 53% compared to T-DM1 If approved,... Read more.
Genentech Provides Update on Phase III persevERA Study in ER-positive Advanced Breast Cancer
persevERA Breast Cancer study did not meet the primary objective of a statistically significant improvement in progression-free survival, but a numerical improvement... Read more.
Report: GCs Say They Are Bullish on Europe
ADVANT research underscores opportunity amid political and economic headwinds, but challenges remain MILAN & MUNICH & PARIS–(BUSINESS WIRE)–Business... Read more.
KYOCERA Document Solutions – “FOREARTH” adopted for ANREALAGE’s Paris Fashion Week AUTUMN/WINTER 2026-27 collection, presented in collaboration with “GHOST IN THE SHELL”
OSAKA, Japan–(BUSINESS WIRE)–KYOCERA Document Solutions Inc. (President: Takashi Nagai) announces that prints produced with its sustainable inkjet textile... Read more.